The use of medications for heart failure and thrombosis (angiotensin-converting enzyme inhibitor [ACEI], angiotensin receptor blocker [ARB], angiotensin receptor–neprilysin inhibitor [ARNI], β-blockers, mineralocorticoid receptor antagonist [MRA], SGLT2 inhibitors, diuretics, antiplatelets, and oral anticoagulants) was not significantly correlated with the change in logBNP (ΔlogBNP) and ΔHb. The gene discussed is NR3C2; the disease is heart failure.